ClinicalTrials.gov
ClinicalTrials.gov Menu

Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01609127
Recruitment Status : Unknown
Verified May 2012 by Genta Incorporated.
Recruitment status was:  Recruiting
First Posted : May 31, 2012
Last Update Posted : June 1, 2012
Sponsor:
Information provided by (Responsible Party):
Genta Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2013
  Estimated Study Completion Date : July 2014